Ask a Question

Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others

* Required field

Your Email Address *

Please enter a valid email address.

Choose a Topic *

Tell us your question and any additional information *

Please enter all required fields.

Please Log In/Join Now first, and then use this function!

Find a Clinical Trial

Researching Genitourinary Cancer

Genitourinary cancer includes bladder, kidney, ovarian, prostate and several other cancers.

Jump to Studies

Bladder and Urinary Tract Cancers | Prostate Cancer | Kidney Cancer | Gynecological Cancer

Genitourinary Cancer Clinical Trials

We are currently investigating experimental medications for bladder, prostate and renal cell (kidney) cancer. Answer a few questions below to see if there are clinical trials that might be right for you.

Thank you for Considering a Clinical Trial

Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).

Here are some options for you to find more information:

Browse the trials available on your own and Click on View Trial Details for more information, including locations that are recruiting patients.
- or -
Let us help you find a trial: Pre-Screen Now and answer a few questions to determine if there is a trial that might be right for you.

Bladder and Urinary Tract Cancer Trials

CA224-020

Recruiting

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

At this time, this study is only recruiting patients for Melanoma and Bladder Cancer.

View Trial Details

CA209-274

Recruiting

An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

View Trial Details

CA209-901

Recruiting

Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer

View Trial Details

CA209-9UT

Recruiting

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

View Trial Details

CA017-078

Recruiting

A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBC

View Trial Details

Prostate Cancer Trials

CA013-004

Recruiting

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

View Trial Details

CA209-650

Recruiting

Study of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer

View Trial Details

CA209-9KD

Recruiting

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

View Trial Details

Kidney Cancer Trials

CA013-004

Recruiting

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

View Trial Details

CA209-914

Recruiting

A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma

View Trial Details

CA209-8KX

Recruiting

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

Recruitment is currently paused for this study.

View Trial Details

Gynecological Cancer Trials

CA209-358

Recruiting

An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

At this time, this protocol is recruiting patients for Cervical Cancer and Merkel Cell Carcinoma only.

View Trial Details

CA209-848

Recruiting

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Recruitment is currently paused for this study.

View Trial Details

Get updates on Genitourinary cancer clinical trials

Get notified when new studies open that might be right for you

Connect with other patients and caregivers on the BMS Clinical Trial Support Community

Share your experiences and learn from others.

Visit Our Community

What are you thankful for?

Read the stories below and send us your own.

"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...

Silver Linings, Breast Cancer - Survivor

View Story

"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...

Silver Linings, Breast Cancer - Survivor

View Story

"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"

Larry and Nancy, Melanoma

View Story

"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"

Larry and Nancy, Melanoma

View Story

"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"

Lucy, Rheumatoid Arthritis

View Story

"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"

Lucy, Rheumatoid Arthritis

View Story

"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"

Tolley, Melanoma

View Story

"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"

Tolley, Melanoma

View Story

All Stories

Explore Genitourinary Cancer Resources

Did You Know There’s a New Kidney Cancer Diagnosis Every 90 Seconds?

Learn More

Prostate Cancer

Did You Know? Video Series

Bristol-Myers Squibb is not affiliated with the creators of this content. The information provided here is for informational purposes only and is not meant to replace a physician's medical advice or imply endorsement. Content in this video may speak to medical topics that are not necessarily related to clinical trials.

Source: NIH (National Institute of Heath) – used with permission 1:49

Bladder Cancer

Source: NIH (National Institute of Heath) – used with permission 1:54

Bladder Cancer

Did You Know? Video Series

Kidney and Renal Pelvis Cancer

Did You Know? Video Series

Source: NIH (National Institute of Heath) – used with permission 3:31

SELECTED SUPPORT ORGANIZATIONS AND DISEASE INFORMATION

Bristol-Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol-Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.

Kidney cancer awareness quiz Help raise awareness for kidney cancer

Early detection, diagnosis and stages American Cancer Society

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -

Call 855-907-3286 or email clinical.trials@bms.com